Early rheumatoid arthritis female patients are mainly treated by general treatment and drug therapy. 1. General treatment: early rheumatoid arthritis should avoid heavy physical labor, actively quit smoking, anti-infection, if necessary, with the functional exercise to restore the local function of the limbs. 2. Drug therapy: the drug therapy for early rheumatoid arthritis includes non-steroidal anti-inflammatory drugs (NSAIDs), slow-acting anti-rheumatic drugs (LAARDs) and glucocorticoids. (1) Non-steroidal anti-inflammatory drugs (NSAIDs): common symptoms of rheumatoid arthritis include morning stiffness, joint swelling and pain, for these symptoms, NSAIDs such as meloxicam, ibuprofen and diclofenac sodium can be given appropriately in order to play an anti-inflammatory and analgesic role, and the gastrointestinal risks during the use of this kind of drugs should be alerted to, and the simultaneous use of two or more NSAIDs should be avoided. (2) Slow-acting antirheumatic drugs: For rheumatoid arthritis, slow-acting antirheumatic drugs, such as methotrexate, leflunomide, elamod, hydroxychloroquine, lancet, adalimumab, infliximab, tofacitib, etc., are needed to control the symptoms of chronic synovitis. (3) Glucocorticosteroids: When anti-inflammatory painkillers are not effective, or when there are corresponding contraindications to taking them, small doses of glucocorticosteroids, such as prednisone acetate tablets, may be added. If the early use of anti-rheumatic drugs can control the development of the disease, generally do not need to add a small dose of glucocorticoids. Rheumatoid arthritis patients should be strictly in accordance with the physician’s instructions for treatment, not unauthorized changes in drug dosage or sudden stopping of medication, it is recommended that patients to the regular hospital rheumatology and immunology department, follow the doctor’s instructions for standardized treatment.